https://ir.volition.com/ https://ir.volition.com/news-events https://ir.volition.com/news-events/press-releases https://ir.volition.com/news-events/video-gallery https://ir.volition.com/news-events/ir-calendar https://ir.volition.com/news-events/presentations-and-reports https://ir.volition.com/news-events/email-alerts https://ir.volition.com/news-events/shareholders-letters https://ir.volition.com/company-information https://ir.volition.com/company-information/executive-team https://ir.volition.com/company-information/contacts https://ir.volition.com/company-information/faq https://ir.volition.com/financial-information https://ir.volition.com/financial-information/financial-results https://ir.volition.com/financial-information/income-statement https://ir.volition.com/financial-information/balance-sheet https://ir.volition.com/financial-information/cash-flow https://ir.volition.com/stock-data/quote-chart https://ir.volition.com/stock-data/historical-data https://ir.volition.com/stock-data/analyst-coverage https://ir.volition.com/sec-filings https://ir.volition.com/sec-filings/all-sec-filings https://ir.volition.com/sec-filings/annual-reports https://ir.volition.com/sec-filings/quarterly-reports https://ir.volition.com/sec-filings/section-16-filings https://ir.volition.com/corporate-governance https://ir.volition.com/corporate-governance/board-of-directors https://ir.volition.com/corporate-governance/board-committees https://ir.volition.com/corporate-governance/governance-documents https://ir.volition.com/news-events/press-releases/detail/882/volitionrx-limited-announces-full-fiscal-year-2025-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/881/volitionrx-secures-eur-2-0-million-of-non-dilutive-funding-from-regional-government-agencies-in-belgium https://ir.volition.com/news-events/press-releases/detail/880/volition-announces-mayo-clinic-study-demonstrates-nu-q-concentrations-are-elevated-in-trauma-patients https://ir.volition.com/news-events/press-releases/detail/879/volition-announces-abstract-demonstrating-risk-stratification-in-lung-cancer-presented-at-the-european-lung-cancer-conference https://ir.volition.com/news-events/press-releases/detail/878/volitionrx-limited-schedules-full-fiscal-year-2025-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/877/volition-announces-detection-of-over-95-of-early-stage-cancers https://ir.volition.com/news-events/press-releases/detail/876/volition-reports-breakthrough-in-liquid-biopsy-achievement-of-over-99-purity-in-isolating-cancer-dna https://ir.volition.com/news-events/press-releases/detail/875/volition-announces-first-ever-automated-nu-q-vet-cancer-test-with-fujifilm-vet-systems https://ir.volition.com/news-events/press-releases/detail/874/volitionrx-highlights-commercial-momentum-and-multi-pillar-execution https://ir.volition.com/news-events/press-releases/detail/873/volition-announces-the-appointment-of-new-distributor-for-nu-q-discover https://ir.volition.com/news-events/press-releases/detail/872/volitionrx-receives-notice-of-non-compliance-with-nyse-american-continued-listing-standards https://ir.volition.com/news-events/press-releases/detail/871/volition-sponsors-symposium-at-15th-conference-of-the-european-hidradenitis-suppurativa-foundation https://ir.volition.com/news-events/press-releases/detail/870/volitionrx-limited-announces-the-preparation-of-reimbursement-submission-for-its-nu-q-cancer-assays https://ir.volition.com/news-events/press-releases/detail/869/volition-announces-data-to-support-use-of-nu-q-nets-in-new-indication https://ir.volition.com/news-events/press-releases/detail/868/volition-continues-to-extend-access-to-nu-q-vet-cancer-test https://ir.volition.com/news-events/press-releases/detail/867/volition-sponsors-symposium-at-veterinary-meeting-and-expo https://ir.volition.com/news-events/press-releases/detail/866/volitionrx-secures-2-0-million-in-funding https://ir.volition.com/news-events/press-releases/detail/865/volitionrx-announces-breakthrough-clinical-data-for-nu-q-vet-cancer-test-in-cats https://ir.volition.com/news-events/press-releases/detail/864/volition-issues-business-review-2025 https://ir.volition.com/news-events/press-releases/detail/863/volition-solves-liquid-biopsys-needle-in-a-haystack-problem-achieves-180-fold-18000-enrichment https://ir.volition.com/news-events/press-releases/detail/862/volition-announces-two-abstracts-were-presented-at-the-north-america-conference-on-lung-cancer https://ir.volition.com/news-events/press-releases/detail/861/volitionrx-limited-announces-inclusion-of-its-nu-q-nets-assay-as-innovative-biomarker-in-frances-real-world-evaluation-of-early-detection-of-sepsis https://ir.volition.com/news-events/press-releases/detail/860/volitionrx-limited-announces-the-first-sale-of-the-nu-q-cancer-assays-for-clinical-certification-in-preparation-for-routine-clinical-use https://ir.volition.com/news-events/press-releases/detail/859/volitionrx-limited-announces-third-quarter-2025-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/858/volitionrx-limited-schedules-third-quarter-2025-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/857/volition-donates-nu-q-vet-cancer-tests-to-hope-animal-assisted-crisis-response-dogs https://ir.volition.com/news-events/press-releases/detail/856/volitionrx-limited-announces-pricing-of-6-0-million-underwritten-public-offering-of-common-stock-and-common-stock-warrants https://ir.volition.com/news-events/press-releases/detail/855/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock-and-common-stock-warrants https://ir.volition.com/news-events/press-releases/detail/854/volition-sponsors-upcoming-genomeweb-webinar https://ir.volition.com/news-events/press-releases/detail/853/volition-signs-co-marketing-and-services-agreement-with-hologic https://ir.volition.com/news-events/press-releases/detail/852/volition-signs-first-human-out-licensing-deal https://ir.volition.com/news-events/press-releases/detail/851/volitionrx-limited-announces-second-quarter-2025-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/850/volitionrx-limited-schedules-second-quarter-2025-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/849/volitionrx-announces-pricing-of-1-2-million-registered-direct-offering https://ir.volition.com/news-events/press-releases/detail/848/nu-q-discover-expands-global-adoption-and-epigenetic-innovation https://ir.volition.com/news-events/press-releases/detail/847/volition-announces-groundbreaking-lateral-flow-test-for-point-of-care-quantification-of-nucleosomes https://ir.volition.com/news-events/press-releases/detail/846/volition-announces-mars-consortium-clinical-study-suggests-nu-q-h3-1-concentrations-are-closely-associated-with-sepsis-and-organ-failure https://ir.volition.com/news-events/press-releases/detail/845/volition-announces-two-oral-presentations-at-asian-meeting-of-animal-medicine-specialties https://ir.volition.com/news-events/press-releases/detail/844/volitionrx-limited-announces-successful-detection-of-nucleosomes-in-cats https://ir.volition.com/news-events/press-releases/detail/843/volitionrx-limited-announces-first-quarter-2025-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/842/volitionrx-limited-schedules-first-quarter-2025-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/841/volitionrx-limited-outlines-broad-strategy-to-become-the-nets-company-worldwide-through-licensing-and-updates-progress-of-nu-q-nets-test-adoption https://ir.volition.com/news-events/press-releases/detail/840/volitionrx-limited-revolutionizing-the-diagnosis-and-monitoring-of-life-altering-diseases-for-both-humans-and-animals-in-multi-billion-dollar-markets https://ir.volition.com/news-events/press-releases/detail/839/volitionrx-limited-announces-full-fiscal-year-2024-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/838/volition-announces-two-poster-presentations-at-esmos-european-lung-cancer-congress-2025 https://ir.volition.com/news-events/press-releases/detail/837/volition-to-host-virtual-investor-event-on-nu-q-cancer-a-look-to-the-future-of-cancer-diagnostics-on-april-9-2025 https://ir.volition.com/news-events/press-releases/detail/836/volitionrx-announces-pricing-of-up-to-2-3-million-registered-direct-offering https://ir.volition.com/news-events/press-releases/detail/835/volitionrx-limited-schedules-full-fiscal-year-2024-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/834/volitions-nu-q-cancer-diagnostics-test-aims-to-disrupt-the-multi-billion-dollar-liquid-biopsy-industry https://ir.volition.com/news-events/press-releases/detail/833/volition-introduces-nu-q-cancer-blood-test-in-new-industry-primer-for-lung-cancer https://ir.volition.com/news-events/press-releases/detail/832/volition-proudly-sponsors-the-44th-isicem-congress https://ir.volition.com/news-events/press-releases/detail/831/volition-signs-first-ever-nu-q-vet-cancer-test-automation-agreement-with-fujifilm-vet-systems https://ir.volition.com/news-events/press-releases/detail/830/volition-announces-first-patient-enrolled-in-ntu-hospitals-prospective-validation-study-of-nu-q-lung-cancer-test https://ir.volition.com/news-events/press-releases/detail/829/volitions-nu-q-discover-biomarkers-to-be-utilized-in-human-clinical-study-sponsored-by-leading-pharmaceutical-company-for-the-first-time https://ir.volition.com/news-events/press-releases/detail/828/volition-showcases-nu-q-vet-cancer-test-at-the-97th-wvc-annual-conference https://ir.volition.com/news-events/press-releases/detail/827/volition-signs-first-commercial-project-utilizing-rapid-high-throughput-model-in-the-study-of-netosis https://ir.volition.com/news-events/press-releases/detail/826/volition-to-host-virtual-investor-event-on-nu-q-nets-casting-a-new-light-on-sepsis-management-on-february-14-2025 https://ir.volition.com/news-events/press-releases/detail/825/large-clinical-study-establishes-nu-q-nets-h3-1-as-an-independent-predictor-of-28-day-mortality-in-sepsis https://ir.volition.com/news-events/press-releases/detail/824/volition-issues-business-review-2024 https://ir.volition.com/news-events/press-releases/detail/823/volitionrx-appoints-lifesci-advisors-as-investor-relations-consultants https://ir.volition.com/news-events/press-releases/detail/822/study-shows-nu-q-lung-cancer-test-differentiated-malignant-and-benign-nodules-found-by-low-dose-ct-screening https://ir.volition.com/news-events/press-releases/detail/821/volitionrx-announces-pricing-of-up-to-1-9-million-registered-direct-offering https://ir.volition.com/news-events/press-releases/detail/820/volitionrx-limited-announces-third-quarter-2024-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/819/volitionrx-limited-schedules-third-quarter-2024-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/818/volition-appoints-timothy-i-still-as-chairman https://ir.volition.com/news-events/press-releases/detail/817/multiple-studies-show-nu-q-nets-test-could-predict-sepsis-patients-at-risk-of-deteriorating https://ir.volition.com/news-events/press-releases/detail/816/volition-to-share-new-nets-in-sepsis-management-data-insights-at-upcoming-webinar https://ir.volition.com/news-events/press-releases/detail/815/volition-hosts-nets-in-sepsis-management-symposium-at-esicm-lives-2024 https://ir.volition.com/news-events/press-releases/detail/814/volition-appoints-dr-ethel-rubin-as-an-independent-director https://ir.volition.com/news-events/press-releases/detail/813/volition-hosts-kol-roundtable-on-sepsis https://ir.volition.com/news-events/press-releases/detail/812/volitionrx-limited-announces-second-quarter-2024-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/811/volitionrx-announces-pricing-of-up-to-21-5-million-registered-direct-offering https://ir.volition.com/news-events/press-releases/detail/810/volitionrx-limited-schedules-second-quarter-2024-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/809/volition-appoints-pharmaventures-for-capture-pcr-and-oncology-portfolio-licensing https://ir.volition.com/news-events/press-releases/detail/808/volitionrx-limited-issues-mid-year-review-ahead-of-2024-annual-meeting https://ir.volition.com/news-events/press-releases/detail/807/volitionrx-limited-to-present-at-jefferies-global-healthcare-conference https://ir.volition.com/news-events/press-releases/detail/806/volitionrx-limited-announces-first-quarter-2024-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/805/volitionrx-limited-schedules-first-quarter-2024-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/804/nu-q-vet-cancer-test-launched-in-clinic-in-u-s-and-europe-through-antech https://ir.volition.com/news-events/press-releases/detail/803/volitionrx-limited-announces-full-fiscal-year-2023-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/802/volitionrx-limited-schedules-fourth-quarter-and-full-year-2023-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/801/volition-and-fujifilm-vet-systems-launch-nu-q-vet-cancer-test-in-japan https://ir.volition.com/news-events/press-releases/detail/800/volition-appoints-dr-andrew-retter-as-chief-medical-officer https://ir.volition.com/news-events/press-releases/detail/799/volition-to-share-nu-q-nets-strategy-update-at-upcoming-webinar https://ir.volition.com/news-events/press-releases/detail/798/volition-issues-business-review-2023 https://ir.volition.com/news-events/press-releases/detail/797/volitionrx-secures-approximately-5-5-million-in-belgium-regional-government-financing-from-wallonie-entreprendre https://ir.volition.com/news-events/press-releases/detail/796/volition-presents-at-the-5th-annual-congress-of-the-international-liquid-biopsy-society https://ir.volition.com/news-events/press-releases/detail/795/volitionrx-limited-announces-third-quarter-2023-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/794/volitionrx-limited-schedules-third-quarter-2023-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/793/volition-and-vpg-launch-nu-q-vet-cancer-test-in-uk-ireland https://ir.volition.com/news-events/press-releases/detail/792/volition-presents-breakthrough-liquid-biopsy-blood-test-method-for-early-stage-cancer https://ir.volition.com/news-events/press-releases/detail/791/measuring-nucleosomes-using-nu-q-nets-is-a-promising-biomarker-for-septic-shock https://ir.volition.com/news-events/press-releases/detail/790/us-ambassador-adler-visits-belgian-volition https://ir.volition.com/news-events/press-releases/detail/789/volition-presents-three-cancer-detection-abstracts-at-esmo-2023 https://ir.volition.com/news-events/press-releases/detail/788/volition-publishes-key-opinion-leader-roundtable-report-on-nets-in-sepsis https://ir.volition.com/news-events/press-releases/detail/787/volition-to-reveal-new-cancer-detection-method-insights-at-upcoming-webinar https://ir.volition.com/news-events/press-releases/detail/786/volition-hosts-key-opinion-leader-roundtable-on-sepsis-management https://ir.volition.com/news-events/press-releases/detail/785/volitionrx-limited-announces-second-quarter-2023-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/784/volitionrx-limited-schedules-second-quarter-2023-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/783/volitionrx-limited-announces-exercise-of-over-allotment-option-by-underwriters https://ir.volition.com/news-events/press-releases/detail/782/volitionrx-limited-announces-closing-of-16-5-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/781/volitionrx-limited-announces-pricing-of-16-5-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/780/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/779/volition-study-shows-nucleosome-concentrations-are-a-useful-tool-for-canine-cancer-treatment-monitoring https://ir.volition.com/news-events/press-releases/detail/778/volitionrx-limited-announces-first-quarter-2023-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/777/volitionrx-limited-schedules-first-quarter-2023-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/776/volitionrx-limited-to-host-capital-markets-day-at-the-nyse-on-thursday-may-11 https://ir.volition.com/news-events/press-releases/detail/775/volitionrx-limited-announces-full-fiscal-year-2022-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/774/volitionrx-limited-schedules-full-year-2022-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/773/volitionrx-limited-announces-closing-of-8-7-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/772/volitionrx-limited-announces-pricing-of-7-525-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/771/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/770/volitions-nu-q-vet-cancer-test-now-available-for-pre-order-at-the-point-of-care-through-heska-corporation https://ir.volition.com/news-events/press-releases/detail/769/volition-to-take-part-in-nu-q-vet-commercial-strategy-webinar https://ir.volition.com/news-events/press-releases/detail/768/volition-announces-expansion-of-availability-of-the-nu-q-vet-cancer-test-through-idexxs-reference-laboratory-network https://ir.volition.com/news-events/press-releases/detail/767/volition-issues-business-review-2022 https://ir.volition.com/news-events/press-releases/detail/766/volitionrx-limited-announces-third-quarter-2022-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/765/volition-announces-clinical-research-study-with-oncovet https://ir.volition.com/news-events/press-releases/detail/764/volition-to-participate-in-a-lung-cancer-screening-study-in-france https://ir.volition.com/news-events/press-releases/detail/763/volitionrx-limited-schedules-third-quarter-2022-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/762/volition-announces-the-launch-of-the-nu-q-vet-cancer-screening-test-in-the-u-s-and-europe-through-heskas-reference-laboratories https://ir.volition.com/news-events/press-releases/detail/761/volition-signs-global-supply-agreement-for-nu-q-vet-cancer-test https://ir.volition.com/news-events/press-releases/detail/760/volition-appoints-mickie-henshall-as-an-independent-director https://ir.volition.com/news-events/press-releases/detail/759/volitionrx-limited-announces-second-quarter-2022-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/758/volition-announces-u-s-clinical-study-for-nets https://ir.volition.com/news-events/press-releases/detail/757/volitionrx-limited-schedules-second-quarter-2022-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/756/volition-appoints-dxocro-to-spearhead-u-s-fda-strategy https://ir.volition.com/news-events/press-releases/detail/755/volitionrx-awarded-1-5-million-in-non-dilutive-funding https://ir.volition.com/news-events/press-releases/detail/754/volitionrx-limited-announces-closing-of-6-9-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/753/volitionrx-limited-announces-pricing-of-6-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/752/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/751/new-nets-data-presented-at-international-society-on-thrombosis-and-haemostasis-isth-congress https://ir.volition.com/news-events/press-releases/detail/750/volition-achieves-ce-mark-for-nu-q-nets-test https://ir.volition.com/news-events/press-releases/detail/749/volitionrx-limited-announces-first-quarter-2022-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/748/volitionrx-limited-schedules-first-quarter-2022-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/747/volitionrx-limited-to-host-capital-markets-day-on-friday-may-13 https://ir.volition.com/news-events/press-releases/detail/746/volition-launches-its-nu-q-vet-cancer-test-in-asia-through-its-appointed-distributor-sage-healthcare https://ir.volition.com/news-events/press-releases/detail/745/volition-appoints-sharon-ballesteros-as-u-s-head-of-quality-and-development-process https://ir.volition.com/news-events/press-releases/detail/744/volitionrx-limited-announces-full-fiscal-year-2021-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/743/volition-signs-exclusive-28-million-license-and-supply-agreement-with-heska-corporation-to-distribute-nu-q-vet-cancer-screening-test-at-the-point-of-care https://ir.volition.com/news-events/press-releases/detail/742/volitionrx-limited-schedules-full-fiscal-year-2021-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/741/volition-presents-study-data-at-asco-gi-2022-on-circulating-nucleosomes-for-the-detection-of-colorectal-cancer-and-high-risk-advanced-adenomas https://ir.volition.com/news-events/press-releases/detail/740/volition-executes-its-first-supply-and-licensing-contract-for-its-nu-q-vet-cancer-screening-test-in-asia https://ir.volition.com/news-events/press-releases/detail/739/volitionrx-limited-announces-third-quarter-2021-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/738/volitionrx-limited-schedules-third-quarter-2021-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/737/volition-veterinary-presents-two-posters-at-the-2021-veterinary-cancer-society-conference https://ir.volition.com/news-events/press-releases/detail/736/volitionrx-limited-announces-second-quarter-2021-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/735/volitionrx-limited-schedules-second-quarter-2021-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/734/volitions-nu-q-nets-assay-demonstrates-promising-results-in-covid-19-risk-stratification-and-disease-monitoring https://ir.volition.com/news-events/press-releases/detail/733/volitionrx-limited-announces-first-quarter-2021-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/732/volitionrx-limited-schedules-first-quarter-2021-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/731/volitionrx-limited-announces-publication-of-significant-nu-q-capture-mass-spectrometry-paper https://ir.volition.com/news-events/press-releases/detail/730/volitionrx-limited-appoints-dr-tom-butera-dvm-as-chief-executive-officer-for-volition-veterinary-subsidiary https://ir.volition.com/news-events/press-releases/detail/729/volitionrx-limited-appoints-two-new-directors https://ir.volition.com/news-events/press-releases/detail/728/volitionrx-limited-announces-full-fiscal-year-2020-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/727/new-data-demonstrates-nu-q-is-effective-in-monitoring-treatment-of-sepsis https://ir.volition.com/news-events/press-releases/detail/726/volitionrx-limited-schedules-full-fiscal-year-2020-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/725/volitionrx-limited-to-present-at-conferences-in-march-2021 https://ir.volition.com/news-events/press-releases/detail/724/volitionrx-limited-announces-closing-of-20-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/723/volitionrx-limited-announces-pricing-of-20-million-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/722/volitionrx-limited-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/721/volitionrx-provides-a-business-update-and-appoints-key-officers-to-drive-commercialization-efforts https://ir.volition.com/news-events/press-releases/detail/720/national-taiwan-university-hospital-presents-data-on-nu-q-assay-performance-at-the-world-conference-on-lung-cancer https://ir.volition.com/news-events/press-releases/detail/719/volitionrx-limited-opens-its-new-manufacturing-facility-in-belgium https://ir.volition.com/news-events/press-releases/detail/718/volitionrx-limited-awarded-an-additional-4-million-in-non-dilutive-funding https://ir.volition.com/news-events/press-releases/detail/717/volitionrx-limited-appoints-dr-tom-butera-dvm-to-board-of-directors https://ir.volition.com/news-events/press-releases/detail/716/volition-launches-nu-q-vet-cancer-screening-test-in-the-u-s https://ir.volition.com/news-events/press-releases/detail/715/volitionrx-limited-to-present-covid-19-data-at-medica-2020 https://ir.volition.com/news-events/press-releases/detail/714/volitionrx-limited-announces-third-quarter-2020-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/713/volition-veterinary-presents-expert-report-ahead-of-first-product-launch https://ir.volition.com/news-events/press-releases/detail/712/volitionrx-limited-schedules-third-quarter-2020-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/711/volitionrx-limited-releases-video-of-virtual-capital-markets-day-2020 https://ir.volition.com/news-events/press-releases/detail/710/volitionrx-limited-announces-details-for-virtual-capital-markets-day-2020 https://ir.volition.com/news-events/press-releases/detail/709/volition-veterinary-diagnostics-development-llc-announces-product-data-regarding-its-nu-q-vet-cancer-screening-test-in-lymphoma-and-hemangiosarcoma-to-be-presented-at-the-2020-vcs-virtual-annual-conference https://ir.volition.com/news-events/press-releases/detail/708/volitionrx-limited-announces-details-for-virtual-capital-markets-day-2020 https://ir.volition.com/news-events/press-releases/detail/707/volition-veterinary-diagnostics-development-llc-to-present-product-data-regarding-its-nu-q-vet-cancer-screening-test-at-the-2020-vcs-virtual-annual-conference https://ir.volition.com/news-events/press-releases/detail/706/volitionrx-limited-announces-virtual-capital-markets-day-2020 https://ir.volition.com/news-events/press-releases/detail/705/volitionrx-limited-to-present-at-conferences-in-september-2020 https://ir.volition.com/news-events/press-releases/detail/704/volitionrx-limited-announces-second-quarter-2020-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/703/volitionrx-limited-schedules-second-quarter-2020-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/702/volition-announces-promising-clinical-trials-results-for-its-novel-covid-19-triage-test https://ir.volition.com/news-events/press-releases/detail/701/volitionrx-releases-business-update-video-and-announces-addition-to-the-russell-3000-and-russell-microcap-indexes https://ir.volition.com/news-events/press-releases/detail/700/volition-announces-cameron-reynolds-president-and-chief-executive-officer-invited-as-presenter-at-maxims-covid-19-virtual-conference https://ir.volition.com/news-events/press-releases/detail/699/volitionrx-announces-closing-of-13-8-million-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/698/volitionrx-announces-pricing-of-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/697/volitionrx-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/696/volitionrx-to-present-first-data-on-nu-q-capture-performance-and-nu-q-assay-performance-in-lung-cancer-and-blood-cancer-at-the-2020-asco-annual-meeting https://ir.volition.com/news-events/press-releases/detail/695/volitionrx-limited-announces-first-quarter-2020-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/694/volitionrx-limited-schedules-first-quarter-2020-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/693/volitions-nu-q-vet-assay-detects-two-common-canine-cancers https://ir.volition.com/news-events/press-releases/detail/692/volition-files-patent-for-nu-qtm-covid-19-triage-test-and-commences-proof-of-concept-studies https://ir.volition.com/news-events/press-releases/detail/691/volitionrx-limited-releases-annual-corporate-brochure-and-video https://ir.volition.com/news-events/press-releases/detail/690/volitionrx-limited-to-present-at-conferences-in-march-2020 https://ir.volition.com/news-events/press-releases/detail/689/volitionrx-limited-announces-full-fiscal-year-2019-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/688/volitionrx-limited-schedules-full-year-2019-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/687/volition-unveils-its-epigenetic-toolbox https://ir.volition.com/news-events/press-releases/detail/686/volitionrx-announces-filing-of-registration-statements https://ir.volition.com/news-events/press-releases/detail/685/volition-develops-a-new-improved-nu-q-assay-format https://ir.volition.com/news-events/press-releases/detail/684/volitionrx-completes-acquisition-of-octamer-gmbh https://ir.volition.com/news-events/press-releases/detail/683/volitionrx-limited-announces-strategic-acquisition https://ir.volition.com/news-events/press-releases/detail/682/volitionrx-and-gyros-protein-technologies-awarded-an-aggregate-1-million-eurostars-cash-grant-to-collaborate-on-developing-a-lung-cancer-blood-test https://ir.volition.com/news-events/press-releases/detail/681/volitionrx-limited-announces-proof-of-concept-data-in-lymphoma-and-leukemia https://ir.volition.com/news-events/press-releases/detail/680/volitionrx-limited-announces-third-quarter-2019-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/678/volitionrx-limited-schedules-third-quarter-2019-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/677/volition-announces-500000-in-non-dilutive-funding-for-volition-veterinary-and-issues-video https://ir.volition.com/news-events/press-releases/detail/676/texas-am-university-takes-a-12-5-equity-stake-in-volition-veterinary-diagnostics-development-llc https://ir.volition.com/news-events/press-releases/detail/675/nu-qtm-vet-pre-analytical-data-to-be-presented-at-the-veterinary-cancer-society-annual-conference-in-houston-texas https://ir.volition.com/news-events/press-releases/detail/674/volition-appoints-dr-phillip-barnes-to-board-of-directors https://ir.volition.com/news-events/press-releases/detail/673/volition-announces-breakthrough-in-enrichment-of-tumor-nucleosomes https://ir.volition.com/news-events/press-releases/detail/672/volitionrx-limited-announces-second-quarter-2019-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/671/volition-forms-texas-based-veterinary-subsidiary-and-appoints-its-chief-executive-officer https://ir.volition.com/news-events/press-releases/detail/670/volitionrx-limited-schedules-second-quarter-2019-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/669/volition-announces-exercise-of-warrant-to-purchase-4-8-million-in-common-stock https://ir.volition.com/news-events/press-releases/detail/668/volitionrx-limited-commences-lung-cancer-clinical-study-with-fosun-long-march-in-china https://ir.volition.com/news-events/press-releases/detail/667/volitionrx-limited-awarded-an-additional-1-4-million-in-non-dilutive-funding https://ir.volition.com/news-events/press-releases/detail/666/volitionrx-limited-announces-first-quarter-2019-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/665/volitionrx-limited-executes-a-contract-for-clinical-trial-program-in-lung-cancer https://ir.volition.com/news-events/press-releases/detail/664/volitionrx-limited-schedules-first-quarter-2019-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/663/volitionrx-limited-hosts-capital-markets-day-at-the-new-york-stock-exchange-and-issues-company-update-report https://ir.volition.com/news-events/press-releases/detail/662/volitionrx-limited-signs-memorandum-of-understanding-with-texas-am-university-for-potential-collaboration-to-develop-nu-qtm-veterinary-diagnostics https://ir.volition.com/news-events/press-releases/detail/661/volitionrx-limited-extends-clinical-trial-program-in-lung-cancer https://ir.volition.com/news-events/press-releases/detail/660/volitionrx-limited-signs-memorandum-of-understanding-with-fosun-long-march-in-china https://ir.volition.com/news-events/press-releases/detail/659/volitionrx-limited-to-present-at-conferences-in-march-april-2019 https://ir.volition.com/news-events/press-releases/detail/658/volitionrx-limited-to-present-at-conferences-in-the-u-s-next-week https://ir.volition.com/news-events/press-releases/detail/657/volitionrx-limited-announces-full-fiscal-year-2018-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/656/volitionrx-limited-schedules-full-year-2018-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/655/volitionrx-limited-announces-third-quarter-2018-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/654/volitionrx-limited-schedules-third-quarter-2018-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/653/volitionrx-limited-to-expand-its-nu-qtm-trials-to-veterinary-diagnostics https://ir.volition.com/news-events/press-releases/detail/652/volitionrx-limited-releases-video-featuring-interviews-with-its-scientific-advisory-board https://ir.volition.com/news-events/press-releases/detail/651/volitionrx-limited-to-attend-multiple-conferences-in-september https://ir.volition.com/news-events/press-releases/detail/650/volitionrx-limited-announces-second-quarter-2018-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/649/preliminary-data-from-study-demonstrates-94-accuracy-in-detecting-aggressive-prostate-cancer https://ir.volition.com/news-events/press-releases/detail/648/volitionrx-limited-announces-completion-of-sample-collection-in-endometriosis-study https://ir.volition.com/news-events/press-releases/detail/647/volitionrx-announces-9-million-private-placement https://ir.volition.com/news-events/press-releases/detail/646/volitionrx-limited-schedules-second-quarter-2018-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/645/volitionrxs-first-research-use-only-product-is-on-the-shelf-today https://ir.volition.com/news-events/press-releases/detail/644/volition-extends-global-reach-of-its-clinical-trial-program https://ir.volition.com/news-events/press-releases/detail/643/volition-secures-additional-700000-non-dilutive-funding-from-the-walloon-region https://ir.volition.com/news-events/press-releases/detail/642/volitionrx-limited-to-attend-the-bank-of-america-merrill-lynch-2018-health-care-conference-from-may-15-17-2018 https://ir.volition.com/news-events/press-releases/detail/641/volitionrx-limited-announces-first-quarter-2018-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/640/volitionrx-signs-a-global-sales-and-distribution-agreement-with-active-motif-for-its-new-ruo-kits https://ir.volition.com/news-events/press-releases/detail/639/volitionrx-limited-schedules-first-quarter-2018-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/638/volitionrx-announces-closing-of-8-4-million-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/637/volitionrx-announces-pricing-of-8-4-million-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/636/volitionrx-announces-proposed-underwritten-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/635/volitionrx-appoints-harvard-professor-dr-lee-jen-wei-to-its-scientific-advisory-board https://ir.volition.com/news-events/press-releases/detail/634/volitionrx-limited-announces-full-fiscal-year-2017-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/633/volitionrx-limited-schedules-full-year-2017-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/632/volitionrx-limited-announces-interim-results-from-680-subject-clinical-trial-in-colorectal-cancer https://ir.volition.com/news-events/press-releases/detail/631/volitionrx-announces-the-successful-conclusion-of-the-logistics-and-pathway-design-study-conducted-in-denmark https://ir.volition.com/news-events/press-releases/detail/630/volitionrx-limited-releases-letter-to-shareholders-including-status-update-on-key-clinical-milestone https://ir.volition.com/news-events/press-releases/detail/629/volitionrx-limited-to-attend-conferences-in-december https://ir.volition.com/news-events/press-releases/detail/628/singapore-volition-signs-memorandum-of-understanding-with-the-national-taiwan-university-to-conduct-two-large-clinical-studies https://ir.volition.com/news-events/press-releases/detail/627/volitionrx-limited-announces-third-quarter-2017-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/626/volitionrx-limited-schedules-third-quarter-2017-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/625/volitionrx-announces-the-initial-sale-of-its-new-nu-qtm-research-kits https://ir.volition.com/news-events/press-releases/detail/624/volitionrx-limited-awarded-1-5-million-in-non-dilutive-funding https://ir.volition.com/news-events/press-releases/detail/623/volitionrx-announces-its-european-colorectal-cancer-strategy https://ir.volition.com/news-events/press-releases/detail/622/volitionrx-to-attend-two-major-conferences-in-asia https://ir.volition.com/news-events/press-releases/detail/621/volition-granted-four-additional-patents https://ir.volition.com/news-events/press-releases/detail/620/volitionrx-limited-to-attend-multiple-conferences-in-september https://ir.volition.com/news-events/press-releases/detail/619/volition-signs-agreement-with-the-institute-of-laboratory-medicine-of-the-technical-university-of-munich-germany-to-assist-in-securing-large-trials-in-a-range-of-cancers https://ir.volition.com/news-events/press-releases/detail/618/volitionrx-limited-announces-second-quarter-2017-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/617/volitionrx-limited-schedules-second-quarter-2017-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/616/volitionrx-limited-to-host-a-conference-call-regarding-a-13500-subject-colorectal-cancer-screening-trial-with-the-early-detection-research-network-of-the-u-s-national-cancer-institute https://ir.volition.com/news-events/press-releases/detail/615/volition-america-inc-announces-a-colorectal-cancer-screening-trial-containing-approximately-13500-subjects-in-collaboration-with-the-early-detection-research-network-of-the-u-s-national-cancer-institute https://ir.volition.com/news-events/press-releases/detail/614/volition-to-present-at-the-europacolon-advocacy-masterclass-and-exhibit-at-the-european-society-for-medical-oncology-gastrointestinal-cancer-congress https://ir.volition.com/news-events/press-releases/detail/613/volitionrx-limited-corrects-an-earlier-announcement https://ir.volition.com/news-events/press-releases/detail/612/volitionrx-limited-to-present-at-multiple-investor-conferences-in-june https://ir.volition.com/news-events/press-releases/detail/611/a-new-publication-reports-that-91-of-colorectal-cancers-were-detected-at-90-specificity-in-a-completed-prospective-trial-using-volitions-nu-qtm-assays https://ir.volition.com/news-events/press-releases/detail/610/volitionrx-limited-announces-first-quarter-2017-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/608/volitionrx-limited-schedules-first-quarter-2017-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/607/volition-makes-progress-with-its-colorectal-cancer-screening-triage-test-in-both-asia-and-europe https://ir.volition.com/news-events/press-releases/detail/606/volition-opens-a-new-research-and-development-facility-in-belgium-with-a-state-of-the-art-purpose-built-laboratory https://ir.volition.com/news-events/press-releases/detail/605/volitionrx-appoints-david-vanston-as-chief-financial-officer https://ir.volition.com/news-events/press-releases/detail/604/volition-america-inc-retains-strategic-expert-in-securing-non-dilutive-funding-opportunities-in-the-united-states https://ir.volition.com/news-events/press-releases/detail/603/volitionrx-limited-announces-the-formation-of-volition-america-inc https://ir.volition.com/news-events/press-releases/detail/602/volitionrx-limited-celebrates-ce-mark-announcement-by-ringing-closing-bell-at-the-new-york-stock-exchange https://ir.volition.com/news-events/press-releases/detail/601/volitionrx-limited-to-ring-the-new-york-stock-exchange-closing-bell-on-monday-march-13th-at-4-pm-eastern-daylight-time https://ir.volition.com/news-events/press-releases/detail/600/volitionrx-limited-announces-full-fiscal-year-2016-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/599/volitionrx-limited-to-present-at-the-29th-annual-roth-conference https://ir.volition.com/news-events/press-releases/detail/598/volitionrx-limited-schedules-fourth-quarter-and-full-year-2016-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/597/a-logistics-and-pathway-design-study-for-volitions-ce-marked-nuqtm-triage-test-has-been-commenced-in-the-capital-region-of-denmark https://ir.volition.com/news-events/press-releases/detail/596/volitionrx-limiteds-triage-test-results-validated-in-prospective-trial https://ir.volition.com/news-events/press-releases/detail/595/volitionrx-limited-to-attend-the-btig-2017-medical-technology-life-sciences-and-diagnostics-conference https://ir.volition.com/news-events/press-releases/detail/594/volitionrx-limited-to-present-at-source-capital-groups-2nd-annual-disruptive-growth-healthcare-conference-on-february-15-2017 https://ir.volition.com/news-events/press-releases/detail/593/volitionrx-limited-strengthens-team-with-key-appointment-to-drive-sales-and-trials-in-asia https://ir.volition.com/news-events/press-releases/detail/592/volitionrx-limiteds-novel-cancer-diagnostic-test-achieves-ce-marking-as-it-prepares-for-launch-across-europe https://ir.volition.com/news-events/press-releases/detail/591/volitionrx-limited-to-present-at-9th-annual-biotech-showcase-conference https://ir.volition.com/news-events/press-releases/detail/590/volitionrx-limited-to-attend-citi-2016-global-healthcare-conference https://ir.volition.com/news-events/press-releases/detail/589/volitionrx-limited-to-present-at-the-canaccord-genuity-medical-technologies-diagnostics-forum-2016 https://ir.volition.com/news-events/press-releases/detail/588/volitionrx-limited-announces-third-quarter-2016-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/587/volitionrx-limited-schedules-third-quarter-2016-earnings-conference-call-and-business-update https://ir.volition.com/news-events/press-releases/detail/586/volitionrx-limited-and-hvidovre-hospital-begin-large-prospective-clinical-study https://ir.volition.com/news-events/press-releases/detail/585/volitionrx-limited-announces-acquisition-of-new-belgian-facility-and-appointment-of-coo-to-belgian-volition https://ir.volition.com/news-events/press-releases/detail/584/volitionrx-limited-announces-exercise-of-over-allotment-option-by-underwriter https://ir.volition.com/news-events/press-releases/detail/583/triage-blood-test-data-presented-to-leading-international-experts-at-the-world-endoscopy-organizations-colorectal-cancer-screening-committee https://ir.volition.com/news-events/press-releases/detail/582/data-presented-at-esmo-2016-demonstrates-that-volitionrx-limiteds-novel-blood-test-for-colorectal-cancer-potentially-reduces-the-need-for-colonoscopy-referral-by-25 https://ir.volition.com/news-events/press-releases/detail/581/volitionrx-limited-announces-closing-of-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/580/volitionrx-limited-announces-pricing-of-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/579/volitionrx-limited-announces-proposed-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/575/volitionrx-to-attend-several-conferences-in-september https://ir.volition.com/news-events/press-releases/detail/574/volitions-nu-q-triage-colorectal-cancer-screening-test-expected-to-reduce-colonoscopy-referral-by-25-percent https://ir.volition.com/news-events/press-releases/detail/573/volitionrx-schedules-product-launch-update-conference-call-for-tuesday-september-6-2016-at-8-30-am-et https://ir.volition.com/news-events/press-releases/detail/572/volitionrx-announces-second-quarter-2016-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/571/volitionrx-schedules-second-quarter-2016-earnings-conference-call-and-business-update-for-thursday-august-11-2016-at-8-30am-et https://ir.volition.com/news-events/press-releases/detail/570/volitionrx-engages-edison-advisors-as-investor-relations-counsel https://ir.volition.com/news-events/press-releases/detail/569/volitionrx-granted-fourth-u-s-patent https://ir.volition.com/news-events/press-releases/detail/568/volitionrx-appoints-dr-edward-futcher-to-board-of-directors https://ir.volition.com/news-events/press-releases/detail/567/volitionrx-publishes-study-confirming-stability-of-circulating-cell-free-nucleosomes-as-biomarkers-for-cancer-diagnostic-blood-tests https://ir.volition.com/news-events/press-releases/detail/566/volitionrx-to-present-at-two-upcoming-conferences-in-june https://ir.volition.com/news-events/press-releases/detail/565/volitionrx-to-present-data-demonstrating-accuracy-of-nuq-blood-test-in-detecting-colorectal-cancer-at-world-endoscopy-organization-weo-meeting https://ir.volition.com/news-events/press-releases/detail/564/volitionrx-announces-first-quarter-2016-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/563/volitionrx-initiates-clinical-trial-with-german-cancer-research-center-dkfz-to-evaluate-nuqr-blood-test-for-pancreatic-cancer https://ir.volition.com/news-events/press-releases/detail/562/volitionrx-schedules-first-quarter-2016-earnings-conference-call-and-business-update-for-friday-may-13-2016-at-8-30am-et https://ir.volition.com/news-events/press-releases/detail/561/volitionrx-announces-study-results-showing-nuq-blood-test-detects-prostate-cancer-early-with-significantly-higher-accuracy-than-psa-test https://ir.volition.com/news-events/press-releases/detail/560/volitionrx-appoints-louise-day-as-chief-marketing-and-communications-officer https://ir.volition.com/news-events/press-releases/detail/559/volitionrx-to-participate-in-2016-morgan-stanley-healthcare-insight-series https://ir.volition.com/news-events/press-releases/detail/558/volitionrx-to-present-at-aacr-annual-meeting-and-announce-first-results-from-prostate-cancer-study https://ir.volition.com/news-events/press-releases/detail/557/volitionrx-announces-ce-marks-for-two-nuq-blood-assays-for-detection-of-colorectal-cancer https://ir.volition.com/news-events/press-releases/detail/556/volitionrx-announces-closing-of-public-offering-of-common-stock-and-exercise-of-over-allotment-option-in-full https://ir.volition.com/news-events/press-releases/detail/555/volitionrx-announces-pricing-of-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/554/volitionrx-announces-proposed-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/553/volitionrx-announces-full-year-2015-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/552/volitionrx-schedules-full-year-2015-earnings-conference-call-and-business-update-for-friday-march-11-2016-at-8-30am-et https://ir.volition.com/news-events/press-releases/detail/551/preliminary-data-demonstrates-86-accuracy-in-detecting-idiopathic-pulmonary-fibrosis-a-fatal-lung-disease https://ir.volition.com/news-events/press-releases/detail/550/volitionrx-demonstrates-75-accuracy-in-detecting-highest-risk-pre-cancerous-colorectal-adenomas-with-nuq-blood-test https://ir.volition.com/news-events/press-releases/detail/549/c-o-r-r-e-c-t-i-o-n----volitionrx-ltd https://ir.volition.com/news-events/press-releases/detail/548/volitionrx-and-cancer-survivor-sean-swarner-celebrate-world-cancer-day-with-message-of-hope-for-cancer-survival-through-early-detection https://ir.volition.com/news-events/press-releases/detail/547/volitionrx-initiates-prostate-cancer-study-in-collaboration-with-the-surrey-cancer-research-institute-university-of-surrey-uk https://ir.volition.com/news-events/press-releases/detail/546/volitionrx-receives-international-iso-certification-for-quality-management-system-of-its-nuqr-blood-tests https://ir.volition.com/news-events/press-releases/detail/545/volitionrx-releases-annual-shareholder-update-letter https://ir.volition.com/news-events/press-releases/detail/544/volitionrx-announces-dr-jason-terrells-transition-to-full-time-status-as-chief-medical-officer-and-head-of-u-s-operations https://ir.volition.com/news-events/press-releases/detail/543/volitionrx-granted-its-third-u-s-patent https://ir.volition.com/news-events/press-releases/detail/542/volitionrx-demonstrates-more-than-90-accuracy-for-colorectal-cancer-nuqr-blood-test-in-completed-prospective-study https://ir.volition.com/news-events/press-releases/detail/541/volitionrx-to-present-at-ld-micro-conference-on-december-3-in-los-angeles https://ir.volition.com/news-events/press-releases/detail/540/volitionrx-demonstrates-nuq-blood-test-detects-lung-cancers-with-more-than-90-accuracy https://ir.volition.com/news-events/press-releases/detail/539/volitionrx-granted-its-second-u-s-patent https://ir.volition.com/news-events/press-releases/detail/538/volitionrx-to-present-at-two-conferences-in-november https://ir.volition.com/news-events/press-releases/detail/537/volitionrx-announces-third-quarter-2015-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/536/volitionrx-schedules-third-quarter-2015-earnings-conference-call-and-business-update-for-wednesday-november-4-2015-at-8-30am-et https://ir.volition.com/news-events/press-releases/detail/535/volitionrx-demonstrates-nuq-blood-test-detects-95-of-pancreatic-cancers-in-second-preliminary-study https://ir.volition.com/news-events/press-releases/detail/534/volitionrx-announces-publication-of-results-from-pancreatic-cancer-study-with-lund-university-in-clinical-epigenetics https://ir.volition.com/news-events/press-releases/detail/533/volitionrx-announces-first-ce-mark-for-nuqr-blood-assay-for-detection-of-colorectal-cancer https://ir.volition.com/news-events/press-releases/detail/532/volitionrx-granted-its-first-u-s-patent https://ir.volition.com/news-events/press-releases/detail/531/volitionrx-demonstrates-nuqr-blood-test-detects-81-of-colorectal-cancers-and-67-of-high-risk-adenomas-in-large-double-blinded-clinical-trial https://ir.volition.com/news-events/press-releases/detail/530/volitionrx-to-present-at-rodman-renshaw-17th-annual-global-investment-conference-in-new-york-and-cnaps-ix-conference-in-berlin-on-september-9-and-11-2015 https://ir.volition.com/news-events/press-releases/detail/529/volitionrx-to-attend-10th-annual-wells-fargo-healthcare-conference-on-september-9-10-2015 https://ir.volition.com/news-events/press-releases/detail/528/volitionrx-announces-appointment-of-david-kratochvil-as-chief-financial-officer https://ir.volition.com/news-events/press-releases/detail/527/volitionrx-announces-second-quarter-2015-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/526/volitionrx-schedules-second-quarter-2015-earnings-conference-call-and-business-update-for-tuesday-august-11-2015-at-8-30am-et https://ir.volition.com/news-events/press-releases/detail/525/volitionrx-to-present-at-wedbush-pacgrow-healthcare-conference https://ir.volition.com/news-events/press-releases/detail/524/volitionrx-engages-specialty-clinical-research-organization-to-support-initial-entry-of-its-nuqr-colorectal-cancer-tests-via-u-s-clia-labs https://ir.volition.com/news-events/press-releases/detail/523/volitionrx-cso-dr-jake-micallef-to-present-scientific-webinar https://ir.volition.com/news-events/press-releases/detail/522/volitionrx-expands-scientific-advisory-board https://ir.volition.com/news-events/press-releases/detail/521/volitionrx-partners-with-two-market-access-consulting-agencies-to-support-market-access-of-nuqr-colorectal-cancer-tests-in-europe https://ir.volition.com/news-events/press-releases/detail/520/volitionrx-to-present-at-two-upcoming-investor-conferences https://ir.volition.com/news-events/press-releases/detail/519/volitionrx-ceo-cameron-reynolds-to-present-informational-webinar https://ir.volition.com/news-events/press-releases/detail/518/volitionrx-announces-first-quarter-2015-financial-results-and-business-update https://ir.volition.com/news-events/press-releases/detail/517/volitionrx-accelerates-clinical-trial-with-university-hospital-bonn-germany-evaluating-nuq-assays-in-most-prevalent-cancers https://ir.volition.com/news-events/press-releases/detail/516/volitionrx-schedules-first-quarter-2015-earnings-conference-call-and-business-update-for-tuesday-may-12-2015-at-8-30-a-m-et https://ir.volition.com/news-events/press-releases/detail/515/volitionrx-initiates-study-with-hvidovre-hospital-denmark-specifically-to-target-nuqr-biomarker-panel-for-colorectal-polyps https://ir.volition.com/news-events/press-releases/detail/514/volitionrx-adds-three-new-laboratory-automation-systems-to-expedite-sample-analysis-for-its-large-ongoing-clinical-trials https://ir.volition.com/news-events/press-releases/detail/504/volitionrx-initiates-second-prostate-cancer-pilot-study-assessing-nucleosomicsr-technology https://ir.volition.com/news-events/press-releases/detail/494/volitionrx-acquires-direct-ownership-of-nucleosomics-technology-patent https://ir.volition.com/news-events/press-releases/detail/484/volitionrx-limited-announces-exercise-of-over-allotment-option-in-previously-announced-public-offering https://ir.volition.com/news-events/press-releases/detail/474/volitionrx-limited-announces-closing-of-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/464/volitionrx-limited-prices-public-offering-of-common-stock https://ir.volition.com/news-events/press-releases/detail/454/volitionrx-begins-first-ovarian-cancer-detection-study https://ir.volition.com/news-events/press-releases/detail/444/initial-study-demonstrates-that-volitionrx-nuq-blood-test-has-84-accuracy-in-detecting-early-stage-treatable-pancreatic-cancers https://ir.volition.com/news-events/press-releases/detail/434/volitionrx-to-initiate-study-with-university-hospital-bonn-to-confirm-nuq-test-accuracy-in-lung-cancer https://ir.volition.com/news-events/press-releases/detail/424/volitionrx-to-present-positive-data-from-pilot-lung-cancer-study-at-biowin-day-2014 https://ir.volition.com/news-events/press-releases/detail/414/volitionrx-enters-agreement-with-university-of-oxford-to-initiate-endometriosis-study https://ir.volition.com/news-events/press-releases/detail/404/volitionrx-to-present-at-the-seethruequity-conference https://ir.volition.com/news-events/press-releases/detail/394/volitionrx-initiates-sponsorship-of-two-time-cancer-survivor-to-drive-awareness-for-the-importance-of-early-cancer-detection https://ir.volition.com/news-events/press-releases/detail/384/volitionrx-presents-further-colorectal-cancer-data-at-9th-international-conference-of-anticancer-research https://ir.volition.com/news-events/press-releases/detail/374/volitionrx-announces-prostate-cancer-collaboration-with-the-university-of-texas-md-anderson-cancer-center https://ir.volition.com/news-events/press-releases/detail/24/volitionrx-nuqr-blood-test-detects-84-of-colorectal-cancers-including-both-early--and-later-stage-cancers https://ir.volition.com/news-events/press-releases/detail/14/volitionrx-to-present-at-the-aegis-capital-corp-2014-healthcare-technology-conference https://ir.volition.com/news-events/press-releases/detail/364/volitionrx-invests-in-laboratory-automation-system-to-increase-throughput-capacity-for-large-clinical-trials https://ir.volition.com/news-events/press-releases/detail/354/volitionrx-announces-new-chief-financial-officer https://ir.volition.com/news-events/press-releases/detail/334/volitionrx-sells-first-nuq-research-use-only-kits-to-active-motif https://ir.volition.com/news-events/press-releases/detail/344/volitionrx-appoints-dr-habib-skaff-to-board-of-directors https://ir.volition.com/news-events/press-releases/detail/314/volitionrx-announces-first-published-data-in-anticancer-research-journal https://ir.volition.com/news-events/press-releases/detail/304/volitionrx-extends-agreement-with-university-hospital-bonn-to-include-ce-mark-performance-evaluation https://ir.volition.com/news-events/press-releases/detail/324/president-and-ceo-of-volitionrx-issues-corporate-update https://ir.volition.com/news-events/press-releases/detail/294/new-volitionrx-study-data-demonstrates-nuqr-assays-high-detection-rate-of-prostate-cancer-and-the-ability-to-distinguish-between-prostate-and-colorectal-cancer https://ir.volition.com/news-events/press-releases/detail/284/volitionrx-completes-3-million-private-placement https://ir.volition.com/news-events/press-releases/detail/264/volitionrx-commences-first-large-clinical-trial-in-collaboration-with-hvidovre-hospital-denmark https://ir.volition.com/news-events/press-releases/detail/274/volitionrx-presents-at-microcapclub-invitational https://ir.volition.com/news-events/press-releases/detail/254/volitionrx-announces-engagement-of-missionir-investor-relations-services https://ir.volition.com/news-events/press-releases/detail/244/volitionrx-finds-simple-blood-test-detects-85-of-colorectal-cancers-and-over-50-of-polyps https://ir.volition.com/news-events/press-releases/detail/234/volitionrx-to-present-at-the-6th-annual-ld-micro-conference https://ir.volition.com/news-events/press-releases/detail/224/volitionrx-expands-sample-size-to-11000-in-pivotal-colorectal-cancer-trial-with-hvidovre-hospital-denmark https://ir.volition.com/news-events/press-releases/detail/214/first-volitionrx-study-data-presented-at-cnaps-baltimore https://ir.volition.com/news-events/press-releases/detail/204/volitionrx-and-active-motif-enter-into-distribution-agreement-for-volitions-research-use-only-elisa-kits https://ir.volition.com/news-events/press-releases/detail/194/volitionrx-led-consortium-awarded-euro-780-000-1m-approx-eurostars-grant https://ir.volition.com/news-events/press-releases/detail/34/volitionrx-to-use-innova-biosciences-biotin-technology-in-its-epigenetic-research-kits https://ir.volition.com/news-events/press-releases/detail/94/volitionrx-embarks-on-colorectal-cancer-trial-with-hvidovre-hospital-denmark https://ir.volition.com/news-events/press-releases/detail/84/racepoint-group-appointed-by-volitionrx-to-raise-awareness-of-its-new-early-stage-cancer-diagnostic https://ir.volition.com/news-events/press-releases/detail/104/volitionrx-files-two-patent-applications https://ir.volition.com/news-events/press-releases/detail/134/volitionrx-hires-head-of-us-operations-jason-terrell-md https://ir.volition.com/news-events/press-releases/detail/54/volitionrx-announces-collaboration-with-wales-cancer-bank https://ir.volition.com/news-events/press-releases/detail/74/volition-launches-nuq-epigenetic-immunoassays-for-research-use https://ir.volition.com/news-events/press-releases/detail/144/volitionrx-to-begin-prospective-clinical-trial-in-colon-cancer https://ir.volition.com/news-events/press-releases/detail/174/volitionrx-issues-ceo-letter-to-shareholders https://ir.volition.com/news-events/press-releases/detail/164/volitionrx-signs-collaboration-agreement-with-stefan-holdenrieder-of-rheinische-friedrich-wilhelms-universitat-bonn-germany https://ir.volition.com/news-events/press-releases/detail/64/volitionrx-raises-over-1-million-to-begin-clinical-trials-of-blood-based-diagnostic-tests https://ir.volition.com/news-events/press-releases/detail/184/pioneering-new-science-nucleosomics-advances-blood-based-diagnostics-for-cancer https://ir.volition.com/news-events/press-releases/detail/154/volition-signs-collaboration-agreement-with-abcodia https://ir.volition.com/news-events/press-releases/detail/124/volitionrx-limited-intellectual-property-update-new-patent-filed https://ir.volition.com/news-events/press-releases/detail/114/volitionrx-limited-issues-525000-shares-to-valirx-final-requirement-of-share-purchase-agreement https://ir.volition.com/news-events/press-releases/detail/44/volition-ticker-symbol-changed-to-vnrx-ob-name-change-to-volitionrx-limited-completed https://ir.volition.com/privacy-policy https://ir.volition.com/disclaimer https://ir.volition.com/sitemap